Chai Discovery’s Post

🚀 Chai Discovery has been named to the Endpoints News 11 list of the most promising biotech companies of 2025! This annual recognition celebrates the most ambitious and innovative biotech startups. In just 12 months since announcing our first funding round, we’ve raised $100M and launched Chai-2: our AI model that can design antibodies on the computer with double-digit success rates. This award reflects our team’s relentless focus on transforming biology from science into engineering. There's no reason to believe the capabilities should plateau here. We look forward to pushing the boundaries of what’s possible at the intersection of biotech and AI.